The exponential innovation leading to the development of intelligent drugs will rely on new therapeutic modalities, all of which have the potential to transform medicine. This chapter discusses groundbreaking approaches that promise to transform medicine through innovations such as regenerative medicine, high-tech organ transplantation, and intelligent prosthetics. The first focus is on the potential of pluripotent stem cells, especially induced pluripotent stem cells (iPSCs), to advance regenerative medicine by overcoming ethical and immunogenic challenges. Despite promising initial trials, widespread therapeutic applications remain elusive. Concurrently, high-tech transplants and artificial organs are being developed to address organ shortages, with 3D printing playing a crucial role in creating biocompatible transplants and custom prosthetics. Nanotechnologies, originating from Richard Feynman’s concept, allow the manipulation of matter at the nanoscale, leading to innovative applications in medicine. Nanomedicines, such as lipid nanoparticles used in mRNA COVID-19 vaccines, enhance drug delivery and targeting, minimizing side effects. Nanoparticles improve diagnostics and therapies, including cancer and infectious disease treatments. Furthermore, current advances in nanorobots and synthetic biology could contribute to revolutionary therapies in the future. Despite their potential, many of these technologies raise ethical and safety concerns due to the manipulation of natural boundaries.

错误:搜索内容不能为空,请输入英文关键词
错误:关键词超出字数限制,请精简
高级检索

Breakthrough Therapeutic Modalities

  • Philippe Moingeon

摘要

The exponential innovation leading to the development of intelligent drugs will rely on new therapeutic modalities, all of which have the potential to transform medicine. This chapter discusses groundbreaking approaches that promise to transform medicine through innovations such as regenerative medicine, high-tech organ transplantation, and intelligent prosthetics. The first focus is on the potential of pluripotent stem cells, especially induced pluripotent stem cells (iPSCs), to advance regenerative medicine by overcoming ethical and immunogenic challenges. Despite promising initial trials, widespread therapeutic applications remain elusive. Concurrently, high-tech transplants and artificial organs are being developed to address organ shortages, with 3D printing playing a crucial role in creating biocompatible transplants and custom prosthetics. Nanotechnologies, originating from Richard Feynman’s concept, allow the manipulation of matter at the nanoscale, leading to innovative applications in medicine. Nanomedicines, such as lipid nanoparticles used in mRNA COVID-19 vaccines, enhance drug delivery and targeting, minimizing side effects. Nanoparticles improve diagnostics and therapies, including cancer and infectious disease treatments. Furthermore, current advances in nanorobots and synthetic biology could contribute to revolutionary therapies in the future. Despite their potential, many of these technologies raise ethical and safety concerns due to the manipulation of natural boundaries.